Optinose

Optinose’s XHANCE Shows Significant Promise in Chronic Sinusitis Treatment: A Breakthrough Revealed in ReOpen Clinical Trials

YARDLEY, PA — Optinose (NASDAQ: OPTN), a Pennsylvania-based pharmaceutical company, has announced the publication of results from its ReOpen1 and ReOpen2 clinical trials. The findings, published in the reputable Journal …

Optinose’s XHANCE Shows Significant Promise in Chronic Sinusitis Treatment: A Breakthrough Revealed in ReOpen Clinical Trials Read More

Windtree Therapeutics

Windtree Therapeutics Strikes Landmark Deal with Lee’s Pharmaceutical for Heart Failure Treatments

WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) has announced a significant license agreement with Lee’s Pharmaceutical (HK) Limited (“Lee’s”), a leading Hong Kong-based pharmaceutical company. The deal involves the …

Windtree Therapeutics Strikes Landmark Deal with Lee’s Pharmaceutical for Heart Failure Treatments Read More

Centrak

CenTrak Clinches IoT Health & Wellness Company of the Year Award for Revolutionizing Healthcare Through Technology

NEWTOWN, PA — CenTrak, a leading provider of Internet-of-Things (IoT) enabled location technology solutions, has been named “IoT Health & Wellness Company of the Year” in the 8th annual IoT …

CenTrak Clinches IoT Health & Wellness Company of the Year Award for Revolutionizing Healthcare Through Technology Read More